this post was submitted on 24 Sep 2024
57 points (100.0% liked)
covid
795 readers
10 users here now
Try to include sources for posts
No Covid misinformation, including anti-vaxx, anti-mask, anti-lockdown takes.
COVID MINIMIZATION = BAN
This community is a safe space for COVID-related discussion. People who minimize/deny COVID, are anti-mask, etc... will be banned.
Off-topic posts will be removed
Jessica Wildfire's COVID bookmark list
COVID-safe dentists: (thanks sovietknuckles)
- https://covidsafeproviders.com/category/covid-safe-dental-dentists/
- https://www.covidsafedentists.ca/
- https://www.covidmeetups.com/en/directory/dentists/US
New wastewater tracking (replacing biobot): https://data.wastewaterscan.org/tracker
founded 2 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
Not medical advice, just sharing research :)
Clinical experience with the α2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in “Long-COVID19”
These are more relevant to either possibly reducing infection or possibly helping with an acute infection. I think that things that may help limit (re)infection are helpful to mention here.
Azelastine:
Antiviral Potential of Azelastine against Major Respiratory Viruses
Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients
Carrageenan:
Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re‐analysis of randomized trial data
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel Dedicated to Patients Care with COVID-19 Disease
Cetylpyridinium Chloride:
Efficacy of Cetylpyridinium Chloride mouthwash against SARS-CoV-2: A systematic review of randomized controlled trials
Melatonin / melatonergic drugs:
these are a bit more dubious
animal testing
Therapeutic potential of melatonin and melatonergic drugs on K18-hACE2 mice infected with SARS-CoV-2Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2
animal testing
Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels